Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Qingzhi Biotechnology is a synthetic biology company that specializes in the microbial production of high-value natural compounds. Founded by academic experts from Xi'an Jiaotong University, the company utilizes metabolic engineering and enzyme evolution to develop efficient microbial strains for industrial fermentation. Their primary product is high-purity ergothioneine, a potent antioxidant used in cosmetics, nutraceuticals, and pharmaceutical research. The company's platform aims to replace traditional, resource-intensive extraction methods with sustainable, bio-based manufacturing processes. Xi'an Qingzhi Biotechnology continues to expand its portfolio to include other rare molecules like salidroside and hydroxytyrosol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Qingzhi Biotechnology.